Sensex
79,809.65 profit arw -270.92 (-0.34%)
Nifty
24,426.85 profit arw -74.05 (-0.30%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 28-Aug-2025
Corporate News
28-Aug-2025     15:43

Sai Life Sciences commissions phase II of its production block in Bidar (Unit IV)

 Sai Life Sciences announced the completion of Phase II of its new Production Block (PB-11) at the company's flagship API manufacturing facility in Bidar, India (Unit IV).

The Phase I of PB-11, with a capacity of 110 KL, was inaugurated in December 2024. With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL, making it the single largest reactor volume block at the Bidar site. This expansion has taken the company's total installed reactor capacity at the Bidar facility to ~700 KL.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

79,809.65 -270.92 (-0.34%)

Nifty

24,426.85 -74.05 (-0.30%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,077.63 78.80(0.32%)